- What's the Analyst Recommendation for Baudax Bio Inc. (BXRX)?
- Let’s Take a Look at Plantronics Inc. (PLT) Stock
- Is it Time to Sell/Buy Isoray Inc. (ISR) Stock After Recent Trade?
- Avis Budget Group Inc. (CAR) is up 12.41% this year
- Code Chain New Continent Limited (CCNC) Stock Price Stood at $1.87 on Tuesday, October 20, What You Think?
Flexion Therapeutics Inc. (FLXN) share price soared 13.86% with the closing price of $13.06 on Tuesday. Flexion Therapeutics Inc. stock has an exchanging volume of 1.75 million shares, which is high, contrasted with its 3-months average volume of 568.30K shares. Its market capitalization has now reached to $637.59M.
Flexion Therapeutics Announces Preliminary Third-Quarter 2020 ZILRETTA® Net Sales of Approximately $23.6 Million on October 13, 2020 news published at Yahoo.
Goldman announced it was Initiated coverage of Flexion Therapeutics Inc. in a research note on August 20, 2020. Oppenheimer rated the stock as an Outperform in a research noted published on July 31, 2020. Credit Suisse rated the stock as an Outperform in a research note published on July 29, 2020.
FLXN Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, FLXN price has rose by 28.04%. In the course of past three months sees the stock go down around -2.90%, while it has gain 65.53% over the past six months and -36.91% since the start of the year.
FLXN Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), the firm recorded a revenue of 15.45 billion, which was higher than the gauge of 21.39M made by certain experts. For that equivalent quarter, Flexion Therapeutics Inc. posted -$0.76 earnings per share (EPS) which was underneath the consensus estimate of -$0.65 by -$0.11, which represents to a reduction by -16.90%.
FLXN Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Flexion Therapeutics Inc. has seen its stock exchanging -9.24% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +29.95% above its three-month low. A more extensive look sees FLXN exchanging -43.17% beneath its 52-week high and 160.68% above from its 52-week low price.
FLXN Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 6.00%, while it has a month to month instability of 5.11%. The company has an ATR (Average True Range) of 0.67 and a beta factor of 1.95.